You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) — Natera announced today that it has partnered with the Fox Chase Cancer Center to evaluate the company's Signatera circulating tumor DNA (ctDNA) assay for monitoring kidney cancer recurrence.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.